Literature DB >> 21532545

Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas.

Juan C Roa1, Oscar Tapia, Asli Cakir, Olca Basturk, Nevra Dursun, Deniz Akdemir, Burcu Saka, Hector Losada, Pelin Bagci, N Volkan Adsay.   

Abstract

The information in the literature on squamous cell and adenosquamous carcinomas of the gallbladder is highly limited. In this study, 606 resected invasive gallbladder carcinoma cases were analyzed. Squamous differentiation was identified in 41 cases (7%). Those without any identifiable glandular-type invasive component were classified as pure squamous cell carcinomas (8 cases) and those with the squamous component constituting 25-99% of the tumors were classified as adenosquamous carcinomas (26 cases) and included into the analysis. The remaining 7 that had <25% squamous component were classified as adenocarcinoma with focal squamous change and excluded. The clinicopathological characteristics of adenosquamous carcinoma/squamous cell carcinomas were documented and contrasted with that of ordinary gallbladder adenocarcinomas. The average patient age was 65 years (range 26-81); female/male ratio, 3.8. In only 13%, there was a preoperative clinical suspicion of malignancy. Grossly, 58% presented as thickening and hardening of the wall and 6% were polypoid. In 12%, mucosa adjacent to the tumor revealed squamous metaplasia. All pure squamous cell carcinomas had prominent keratinization. Giant cells and tumor-infiltrating eosinophils were observed in 29 and 51% of the squamous cell carcinomas/adenosquamous carcinomas versus 10% (P=0.02) and 6% (P=0.001) in gallbladder adenocarcinomas, respectively. All but three cases had 'advanced' (pT2 and above) carcinomas. Follow-up was available in 31 patients: 25 died of disease (median=5 months, range 0-20), and 6 were alive (median=64 months, range 5-112.5). The survival of patients with squamous cell carcinomas/adenosquamous carcinomas was significantly worse than that of gallbladder adenocarcinomas (P=0.003), and this adverse prognosis persisted when compared with stage-matched advanced gallbladder adenocarcinoma cases (median=11.4 months, P=0.01). In conclusion, squamous differentiation was noted in 7% of gallbladder carcinomas. The incidence of adenosquamous carcinoma (defined as 25-99% of the tumor being squamous) was 4%, and that of pure squamous cell carcinoma (without any documented invasive glandular component) was 1%. Pure squamous cell carcinomas often showed prominent keratinization. The overall prognosis of adenosquamous carcinoma/squamous cell carcinoma appears to be even worse than that of ordinary adenocarcinomas. Most patients died within a few months; however, those few who were alive beyond 2 years in this cohort experienced long-term survival.

Entities:  

Mesh:

Year:  2011        PMID: 21532545     DOI: 10.1038/modpathol.2011.68

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  46 in total

1.  Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.

Authors:  Orhun Cig Taskin; Gizem Akkas; Bahar Memis; Ipek Erbarut Seven; Olca Basturk; Kee-Taek Jang; Juan C Roa; Juan Carlos Araya; Enrique Bellolio; Hector Losada; Juan Sarmiento; Serdar Balci; Burcin Pehlivanoglu; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2019-06-08       Impact factor: 4.064

2.  Adjuvant chemoradiotherapy for squamous cell carcinoma of gallbladder.

Authors:  Supriya Mallick; Rony Benson; P K Julka; Goura Kishor Rath
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.

Authors:  Jianning Sun; Zhu-Lin Yang; Xiongying Miao; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

4.  Squamous Cell and Adenosquamous Carcinoma of Gall Bladder: a Clinicopathological Study of 8 Cases Isolated in 94 Cancers.

Authors:  Hanni Vasudev Gulwani; Suneeta Gupta; Sukhpreet Kaur
Journal:  Indian J Surg Oncol       Date:  2017-05-03

5.  Pure Squamous Cell Carcinoma of the Gallbladder Masquerading as a Hepatic Mass.

Authors:  Abhilash Perisetti; Saikiran Raghavapuram; Benjamin Tharian; Irfan Warraich; Fred Hardwicke; Rubayat Rahman; Edwin Onkendi
Journal:  Cureus       Date:  2018-01-01

6.  Primary Pure Keratinising Squamous Cell Carcinoma: A Rare Malignancy with Aggressive Behaviour.

Authors:  Mansi Chandna; Leela Pant; Malini Garg; Garima Singh; Sompal Singh
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Prothymosin-α and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.

Authors:  Kang Chen; Li Xiong; Zhuling Yang; Shengfu Huang; Rong Zeng; Xiongying Miao
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

8.  ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-Lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Tumour Biol       Date:  2012-10-13

9.  A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Authors:  Zhulin Yang; Zhi Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

10.  Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Xiongying Miao; Zhu-Lin Yang; Li Xiong; Qiong Zou; Yuan Yuan; Jinghe Li; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.